Two ingredients used in nail modelling cosmetics will be prohibited in EU by the CMR Omnibus Act VII
Ingredients: DIMETHYLTOLYLAMINE, TRIMETHYLBENZOYL DIPHENYLPHOSPHINE OXIDE

Proposed date of adoption: 20 days from publication in the OJEU

The European Commission notified the WTO of the draft text for the 21st Adaptation to Technical Progress (ATP) to the EU CLP Regulation. Two cosmetic nail modelling ingredients will be prohibited in EU.

At the beginning of March, 2023, the EU Commission notified the World Trade Organisation (WTO) of the draft text for the 21st Adaptation to Technical Progress (ATP) to the EU Classification, Labelling and Packaging (CLP) Regulation.

The draft ATP amends Annex VI of the EU CLP Regulation, including new Carcinogenic, Mutagenic and Reprotoxic (CMR) classifications relating to the following cosmetic ingredients used in nail cosmetic products:

  • Dimethyltolylamine, carcinogenic 1B – no current Annex entry in the EU Cosmetics Regulation
  • Trimethylbenzoyl diphenylphosphine oxide, reprotoxic 1B – currently listed in Annex III entry 311 of the EU Cosmetics Regulation

These ingredients were not defended by industry and will therefore be included in Annex II (prohibited substances) of the EU Cosmetics Regulation 1223/2009 via the 7th CMR Omnibus Regulation.

The making available (off-shelf) deadline for products containing these substances will be 18 months after publication of the 21st ATP to CLP on the Official Journal of the European Union.

It is important to note that this new regulation will not automatically be included within the Great Britain CLP Regulation.  So currently, the announced bans will apply only in the European Union.

References:

1. World Trade Organization – Notification G/TBT/N/EU/957

other REGULATORY UPDATES

Regulation (EU) 2022/1531 – OMNIBUS ACT V – applicable as of 17 December 2022

Ingredients: METHYL SALICYLATE, SODIUM HYDROXYMETHYLGLYCINATE, DBMC, MIBK

Date of publication: 15/09/2022

Date of application: 17/12/2022

The European Commission has published the Commission Regulation (EU) 2022/1531, which amends the Regulation (EC) No 1223/2009 as regards the use in cosmetic products of certain substances classified as CMR, by adding new entries to Annex II and Annex III and revising an entry in Annex V.

Read More »
Any REGULATORY QUESTION?

SCCS Preliminary Opinion on Sodium Bromothymol Blue (C186) as hair dyeing

Ingredients: SODIUM BROMOTHYMOL BLUE (C186)

Date of publication: 28/10/2022

Following the request from the EU Commission for a scientific opinion on the hair dye Sodium Bromothymol Blue (C186), on October 2022 the Scientific Committee on Consumer Safety (SCCS) issued a preliminary opinion. In light of the data provided, when used in non-oxidative hair colouring products up to a maximum on-head concentration of 0.5%, the SCCS is of the opinion that the complete safety of Sodium Bromothymol Blue could not be assessed.

Read More »

Regulation (EU) 2022/1531 – OMNIBUS ACT V – applicable as of 17 December 2022

Ingredients: METHYL SALICYLATE, SODIUM HYDROXYMETHYLGLYCINATE, DBMC, MIBK

Date of publication: 15/09/2022

Date of application: 17/12/2022

The European Commission has published the Commission Regulation (EU) 2022/1531, which amends the Regulation (EC) No 1223/2009 as regards the use in cosmetic products of certain substances classified as CMR, by adding new entries to Annex II and Annex III and revising an entry in Annex V.

Read More »